Department of Internal Medicine II, Division of Diabetes, Nutrition and Metabolic Diseases, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Sq. no. 2, 300041 Timișoara, Romania.
Center for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, "Victor Babeș" University of Medicine and Pharmacy, Eftimie Murgu Sq. no. 2, 300041 Timișoara, Romania.
Medicina (Kaunas). 2021 Sep 16;57(9):973. doi: 10.3390/medicina57090973.
: It is known that several viruses are involved in the pathogenesis of type 1 diabetes. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new worldwide spread virus that may act as a trigger for the autoimmune destruction of the β-cells, as well, and thus lead to an increase in the incidence of type 1 diabetes. The Romanian National Organization for the Protection of Children and Adolescents with Diabetes (ONROCAD) has collected information regarding new cases of type 1 diabetes in children aged 0 to 14 years from all over the country since 1996 and has computed the incidence of type 1 diabetes in this age group. We observed a marked increase in the incidence of type 1 diabetes in the first year of the COVID-19 pandemic, with 16.9%, from 11.4/100,000 in 2019 to 13.3/100,000 in 2020, much higher compared to previous years (mean yearly increase was 5.1% in the period 1996-2015 and 0.8% in the interval 2015-2019). The proportion of newly diagnosed cases was significantly higher in the second half of 2020 compared to the second half of the previous years (57.8 vs. 51%, < 0.0001). All these aspects suggest the role that SARS-CoV-2 could have in triggering pancreatic autoimmunity. To confirm this, however, collecting information from larger populations from different geographical regions, monitoring the incidence curves over a period of several years, and gathering background information on COVID-19 and/or data on COVID-19 specific antibodies are needed.
已知有几种病毒参与了 1 型糖尿病的发病机制。严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)是一种新的全球传播病毒,它也可能作为β细胞自身免疫破坏的触发因素,从而导致 1 型糖尿病发病率的增加。
罗马尼亚全国儿童和青少年糖尿病保护组织(ONROCAD)自 1996 年以来一直在全国范围内收集 0 至 14 岁儿童新发 1 型糖尿病病例的信息,并计算了该年龄段 1 型糖尿病的发病率。我们观察到,在 COVID-19 大流行的第一年,1 型糖尿病的发病率显著增加,达到 16.9%,从 2019 年的 11.4/100,000 上升到 2020 年的 13.3/100,000,与前几年相比明显升高(1996-2015 年期间平均每年增长 5.1%,2015-2019 年期间增长 0.8%)。与前几年相比,2020 年下半年新诊断病例的比例显著更高(57.8%对 51%,<0.0001)。所有这些方面都表明 SARS-CoV-2 可能在引发胰腺自身免疫中发挥作用。然而,要证实这一点,需要从不同地理区域的更大人群中收集信息,监测几年的发病率曲线,并收集有关 COVID-19 的背景信息和/或 COVID-19 特异性抗体的数据。